InflaRx (IFRX) Enterprise Value (2016 - 2026)

InflaRx has disclosed Enterprise Value across 11 years of filings, most recently posting -$29042.6 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$29042.6 billion, down 74723111.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$29042.6 billion (down 74723111.71% YoY), and the FY2025 annual result was -$35427.8 billion, down 85602086.34% from the prior year.
• Enterprise Value came in at -$29042.6 billion for Q1 2026 at InflaRx, up from -$35427.8 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$7.5 million in Q3 2025 to a low of -$35427.8 billion in Q4 2025.
• The 5-year median for Enterprise Value is -$82.7 million (2022), against an average of -$3792.4 billion.
• Across the five-year window, Enterprise Value soared 100.0% in 2022 and tumbled 85602086.34% in 2025, its largest moves.
• InflaRx's Enterprise Value stood at -$82.7 million in 2022, then retreated by 17.42% to -$97.1 million in 2023, then soared by 57.39% to -$41.4 million in 2024, then sank by 85602086.34% to -$35427.8 billion in 2025, then gained by 18.02% to -$29042.6 billion in 2026.
• The last three Enterprise Value figures came in at -$29042.6 billion (Q1 2026), -$35427.8 billion (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.